Close
Back to ENZN Stock Lookup

Enzon Pharma (ENZN) – Major News

Mar 21, 2016 04:19 PM Enzon Pharma (ENZN) Appoints New CEO, CFO; Announces Other Management Changes
Apr 23, 2013 04:06 PM Enzon Pharma (ENZN) Concludes Sale Review; Declares $1.60/Sh. Special Div.
Mar 18, 2013 05:10 PM Enzon Pharmaceuticals, Inc. (ENZN) Widens Q4 Loss to 11c/Share
Dec 17, 2012 07:03 AM Enzon Pharmaceuticals (ENZN) Suspends Clinical Development, To Explore a Sale
Oct 31, 2012 07:11 AM Enzon Pharmaceuticals, Inc. (ENZN) Swings to Q3 Profit of 8c/Share
Aug 1, 2012 07:12 AM Enzon Pharmaceuticals, Inc. (ENZN) Narrows Q2 Loss to 2c/Share
May 2, 2012 08:02 AM Enzon Pharmaceuticals, Inc. (ENZN) Swings to Q1 Loss
Mar 12, 2012 08:11 AM Enzon Pharmaceuticals, Inc. (ENZN) Reports Q4 Loss of $0.10
Nov 3, 2011 04:37 PM Enzon Pharmaceuticals, Inc. (ENZN) Widens Q3 Loss on Lighter Sales
Aug 4, 2011 08:29 AM Enzon Pharmaceuticals, Inc. (ENZN) Misses Q2 EPS by 13c
May 6, 2011 08:03 AM Enzon Pharmaceuticals, Inc. (ENZN) Tops Q1 EPS by 4c
Nov 2, 2010 03:32 PM Enzon Pharma (ENZN) Posts Q3 Loss of 14c, Misses Views; Won't Pursue Pegintron Royalty Stream
May 10, 2010 09:12 AM Enzon Pharmaceuticals Inc. (ENZN) Posts Q1 adj.-Loss of $0.20, Wider than Vews
Feb 22, 2010 07:42 AM Enzon Pharmaceuticals (ENZN) CEO to Resign
Feb 17, 2010 08:56 AM Enzon Pharmaceuticals Inc. (ENZN) Posts Q4 Break Even EPS, Beats by 9c
Nov 9, 2009 08:39 AM Enzon Pharmaceuticals (ENZN) Sells Specialty Pharmaceutical Business for Up to $327M and Royalties
Nov 3, 2009 08:51 AM Enzon Pharma (ENZN) Reports Breakeven Q3 Results
Feb 19, 2009 09:28 AM Enzon Pharma (ENZN) Reports Q4 Loss of $0.13, Beats by 3c
Feb 10, 2009 08:26 AM Enzon Pharma (ENZN) Ends Development of rhMBL, Announces Survivin Antagonist IND Accepted
Nov 5, 2008 09:06 AM Enzon Pharmaceuticals (ENZN) Reports Q3 Loss of $0.05, Beats by 10c
Aug 11, 2008 08:32 AM Enzon Pharma (ENZN) To Explore Options for Specialty Pharmaceuticals Business
Aug 6, 2008 08:26 AM Enzon Pharmaceuticals (ENZN) Reports Q2 Loss of $0.04
May 7, 2008 08:50 AM Enzon Pharmaceuticals (ENZN) Reports Q1 EPS of $0.03, Beats By 12c
Feb 14, 2008 07:48 AM Enzon Pharmaceuticals (ENZN) Reports Q4 EPS of $0.01, Tops Street Estimate of ($0.28)

Back to ENZN Stock Lookup